RQM+ Launches AI Center of Excellence for AI-Enabled Medical Devices and Diagnostics

NewsTechTrendsRQM+ Launches AI Center of Excellence for AI-Enabled Medical Devices and Diagnostics

PITTSBURGH–(BUSINESS WIRE)–RQM+, a leading MedTech CRO offering regulatory consulting, clinical trial, laboratory, and reimbursement services, today announced that it has launched its AI Center of Excellence (CoE) to help companies meet the regulatory, clinical, and quality requirements for AI-enabled medical devices and in vitro diagnostics (IVDs).

The AI CoE brings together AI, regulatory, clinical, and IVD expertise from across RQM+ to support companies as AI adoption in MedTech moves faster than regulatory clarity and the EU Artificial Intelligence Act (AI Act) adds new requirements on top of the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR).

“Many AI and software companies building healthcare tools think of themselves as software developers and may not realize their product is regulated as a medical device or an IVD,” said Bethany Chung, Ph.D., head of the AI Center of Excellence and director of technical solutions and innovation at RQM+. “Companies need a partner who understands both the traditional device and the implications of adding AI into the product, and who can help them enter the regulated space the right way from the start.”

The AI CoE supports three groups of companies facing distinct challenges with AI in medical devices:

  • AI and software developers new to device regulation: Guidance on classification, regulatory pathway, clinical evidence, and technical documentation for software as a medical device (SaMD) and IVDs, particularly under IVDR
  • Manufacturers using AI in their own processes: Support for keeping AI-assisted activities, such as clinical evaluation, compliant with quality standards including ISO 13485
  • Device makers integrating AI into complex devices: Combined device and AI regulatory strategy for products that pair AI with traditional and high-risk devices

“AI in diagnostics remains underaddressed, and software developers entering the IVD space often find that IVDR asks more of them than they expected,” said Samy Puccio, director of IVD global regulatory affairs at RQM+. “Bringing IVD regulatory expertise into the AI Center of Excellence means those companies can plan for those requirements from the start.”

The AI CoE operates within the RQM+ consulting services team, giving clients access to regulatory, quality, and clinical expertise across the device life cycle, including through SMART Solutions, the RQM+ life cycle partnership model.

MedTech and software companies can learn more about the RQM+ AI Center of Excellence and meet the team.

About RQM+

RQM+ is a leading MedTech service provider offering consulting, clinical trial, lab, and reimbursement services, as well as technology solutions to support the entire product life cycle.

Read More : 

Social Intelligence vs. Social Listening: Understanding the Difference for Businesses

FPGA vs GPU: Performance, Power, Cost, and Key Differences

Related News